Rate and predictors of progression in elite and viremic HIV-1 controllersAgathe León, Felipe García, José López-Aldeguer et al.|AIDS|2016Cited by 84
Factors Leading to the Loss of Natural Elite Control of HIV-1 InfectionMaría Pernas, Ezequiel Ruíz-Mateos, Laura Tarancón‐Díez et al.|Journal of Virology|2017Cited by 78
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Constanza Lucero, Núria Climent et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 65
Analysis of Non-AIDS-Defining Events in HIV ControllersBeatriz Domínguez-Molina, Ezequiel Ruíz-Mateos, Agathe León et al.|Clinical Infectious Diseases|2016Cited by 47